Business
AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm on March 11
STOCKHOLM, SE / ACCESS Newswire / March 4, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced ...
About this update from Alzecure Pharma Ab
[{"type":"text","content":"STOCKHOLM, SE / ACCESS Newswire / March 4, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the company's CEO Martin Jönsson will present at Stora Aktiedagarna in Stockholm, Sweden, hosted by Aktiespararna, at 08:50 CET on March 11.","length":401,"tagName":"p"},{"type":"text","content":"In his presentation, Martin Jönsson will provide an update on the company's recent developments and strategic plans going forward, with a focus on the company's project portfolio and its drug candidates from the research platforms NeuroRestore®, Alzstatin® and Painless. The presentation will be followed by a Q&A led by Aktiespararna's moderator.","length":363,"tagName":"p"},{"type":"text","content":"The live broadcast is available via the following link: https://invitepeople.com/public/events/ad0e0ffac7/pages/af1743879f","length":122,"tagName":"p"},{"type":"text","content":"The presentation will also be available on the company's website afterwards: https://www.alzecurepharma.se/en/presentations-and-interviews/","length":143,"tagName":"p"},{"type":"text","content":"For more information about the event and to register to attend the Birger Jarl Conference in Stockholm, please see here: https://www.aktiespararna.se/aktiviteter/stora-aktiedagarna-i-stockholm-67703","length":198,"tagName":"p"},{"type":"text","content":"Event time: March 10, 08:00 CET - March 11, 20:00 CETPresentation time: March 11, 08:50 CETVenue: Birger Jarl Konferens, Birger Jarlsgatan 61 A, Stockholm, Sweden","length":164,"tagName":"p"},{"type":"text","content":"For more information, please contact","length":36,"tagName":"p"},{"type":"text","content":"Martin Jönsson, CEOTel: +46 707 86 94 [email protected]","length":75,"tagName":"p"},{"type":"text","content":"About AlzeCure Pharma AB (publ)","length":31,"tagName":"p"},{"type":"text","content":"AlzeCure® is a Swedish clinical stage biotech company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer's disease and pain - indications for which currently available treatment is very limited. The company is listed on Nasdaq First ...